Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Kei Takuma"'
Autor:
Tomoko Tadokoro, Joji Tani, Takushi Manabe, Kei Takuma, Mai Nakahara, Kyoko Oura, Shima Mimura, Koji Fujita, Takako Nomura, Asahiro Morishita, Hideki Kobara, Takashi Himoto, Masafumi Ono, Tsutomu Masaki
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Portal vein thrombosis (PVT) worsens the long-term prognosis of patients with cirrhosis; however, the optimal treatment remains to be determined. Reports on the efficacy of direct oral anticoagulants are increasing, and further evidence is n
Externí odkaz:
https://doaj.org/article/edf0293d1b7b41aca4d8da2b8ed176f0
Autor:
Tomoko Tadokoro, Takako Nomura, Koji Fujita, Takushi Manabe, Kei Takuma, Mai Nakahara, Kyoko Oura, Shima Mimura, Joji Tani, Asahiro Morishita, Hideki Kobara, Masafumi Ono, Tsutomu Masaki
Publikováno v:
BMC Gastroenterology, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Hepatocellular carcinoma (HCC) in autoimmune hepatitis (AIH) was considered rare but is increasing with prolonged prognosis. Its impact on the overall prognosis of AIH is unknown, and treatment has not been established. Aim To inv
Externí odkaz:
https://doaj.org/article/b1e1db6200a24ae49e2fc299f5bec07e
Autor:
Kyoko Oura, Asahiro Morishita, Kei Takuma, Mai Nakahara, Tomoko Tadokoro, Koji Fujita, Shima Mimura, Joji Tani, Masafumi Ono, Takashi Himoto, Tsutomu Masaki
Publikováno v:
Cancer Medicine, Vol 12, Iss 24, Pp 22023-22037 (2023)
Abstract Aim Indications of drug therapies to elderly patients with hepatocellular carcinoma (HCC) should be carefully determined. The current study assessed the safety and efficacy of molecular targeted agents (MTAs) in the elderly patients with HCC
Externí odkaz:
https://doaj.org/article/1f9fc393f2c049ff98af5d20111cb879
Autor:
Yudai Sato, Tomoko Tadokoro, Hiroki Yamana, Hiraki Akai, Kei Takuma, Naoki Fujita, Mai Nakahara, Kyoko Oura, Koji Fujita, Joji Tani, Hideki Kamada, Asahiro Morishita, Hideki Kobara, Seiko Kagawa, Reiji Haba, Keiichi Okano, Tsutomu Masaki
Publikováno v:
DEN Open, Vol 4, Iss 1, Pp n/a-n/a (2024)
Abstract Hepatocellular carcinoma invasion of the bile duct is rare and has a poor prognosis. A 77‐year‐old man presented at the emergency department with persistent pain in the right hypochondrium. Blood tests and imaging studies revealed a 70
Externí odkaz:
https://doaj.org/article/fc380b8c52934850ae901bdfcd046599
Autor:
Takushi Manabe, Chikara Ogawa, Kei Takuma, Mai Nakahara, Kyoko Oura, Tomoko Tadokoro, Koji Fujita, Joji Tani, Mitsushige Shibatoge, Asahiro Morishita, Masatoshi Kudo, Tsutomu Masaki
Publikováno v:
Diagnostics, Vol 13, Iss 7, p 1245 (2023)
Computed tomography (CT) is often used in the diagnosis of sarcopenia. In this study, we validated the assessment of sarcopenia by the psoas muscle volume using versatile software. The study involved a retrospective analysis of data from 190 patients
Externí odkaz:
https://doaj.org/article/5ff2be9a7cca42cf9665019dbaddfdd5
Autor:
Asahiro Morishita, Tomoko Tadokoro, Shintaro Fujihara, Hisakazu Iwama, Kyoko Oura, Koji Fujita, Joji Tani, Kei Takuma, Mai Nakahara, Tingting Shi, Reiji Haba, Keiichi Okano, Akira Nishiyama, Masafumi Ono, Takashi Himoto, Tsutomu Masaki
Publikováno v:
PLoS ONE, Vol 17, Iss 2 (2022)
Non-alcoholic steatohepatitis (NASH) is a common chronic liver disease with no decisive treatment. The sodium glucose cotransporter 2 (SGLT2) inhibitor ipragliflozin was developed as a new oral hypoglycemic drug, which can improve NASH via an insulin
Externí odkaz:
https://doaj.org/article/e9f282999d36468ca73046c8c50f29d2
Autor:
Masaki, Kyoko Oura, Asahiro Morishita, Takushi Manabe, Kei Takuma, Mai Nakahara, Tomoko Tadokoro, Koji Fujita, Shima Mimura, Joji Tani, Masafumi Ono, Chikara Ogawa, Akio Moriya, Tomonori Senoo, Akemi Tsutsui, Takuya Nagano, Koichi Takaguchi, Takashi Himoto, Tsutomu
Publikováno v:
Cancers; Volume 15; Issue 12; Pages: 3243
Although there have been advances in the prevention and diagnosis of hepatocellular carcinoma (HCC) in recent years, many HCC patients are still diagnosed with advanced stage. Systemic therapy is indicated for unresectable HCC (uHCC) with major vascu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::4d2a00f84c62dc2b578789d9caf9fe00
Autor:
Tomoko Tadokoro, Joji Tani, Kei Takuma, Mai Nakahara, Kyoko Oura, Koji Fujita, Shima Mimura, Masafumi Ono, Asahiro Morishita, Tsutomu Masaki
Publikováno v:
Kanzo. 63:107-119
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4d7be6014e11279ff65ca74257f8e9c
https://doi.org/10.2957/kanzo.63.107
https://doi.org/10.2957/kanzo.63.107
Autor:
SAE HAMAYA, SHINTARO FUJIHARA, HISAKAZU IWAMA, KOJI FUJITA, TINGTING SHI, RYOTA NAKABAYASHI, TAKAAKI MIZUO, KEI TAKUMA, MAI NAKAHARA, KYOKO OURA, TOMOKO TADOKORO, SHIMA MIMURA, JOJI TANI, ASAHIRO MORISHITA, HIDEKI KOBARA, MASAFUMI ONO, TAKASHI HIMOTO, TSUTOMU MASAKI
Publikováno v:
Anticancer Research. 42:1263-1275
Drug resistance to molecular targeted agents, such as lenvatinib, is an important issue. The aim of this study was to explore the mechanism of lenvatinib resistance and to investigate potential drugs that may improve the treatment of lenvatinib-resis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b919d795f4458e8e82399aac10c7557
https://doi.org/10.21873/anticanres.15593
https://doi.org/10.21873/anticanres.15593
Autor:
Asahiro Morishita, Kyoko Oura, Kei Takuma, Mai Nakahara, Tomoko Tadokoro, Koji Fujita, Joji Tani, Tingting Shi, Takashi Himoto, Miwa Tatsuta, Akio Moriya, Tomonori Senoo, Akemi Tsutsui, Takuya Nagano, Koichi Takaguchi, Masafumi Ono, Tsutomu Masaki
Publikováno v:
Hepatology international.
Background This retrospective, multicenter study evaluated the effect of pemafibrate treatment on liver function and fibrosis by liver function tests (LFTs) and various fibrotic biomarkers including FibroScan in non-alcoholic fatty liver disease (NAF
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9196425592efbb7ec228bc522da6514e
https://pubmed.ncbi.nlm.nih.gov/36583842
https://pubmed.ncbi.nlm.nih.gov/36583842